Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)

NCT07687706 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1524

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Ischemic Stroke, Acute
Transient Ischemic Attack (TIA)
Cerebrovascular Disease
Gastrointestinal Complication
Gastrointestinal Bleeding

Interventions

DRUG: Tegoprazan 50 mg
DRUG: Placebo

Sponsor

Hanyang University Guri Hospital

Collaborators

[object Object]